Glycopyrrolate and Anaphylaxis - a phase IV clinical study of FDA data

Summary:

Anaphylaxis is found among people who take Glycopyrrolate, especially for people who are female, 60+ old, have been taking the drug for 1 - 6 months.

The phase IV clinical study analyzes which people take Glycopyrrolate and have Anaphylaxis. It is created by eHealthMe based on reports of 3,707 people who have side effects when taking Glycopyrrolate from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Feb, 07, 2023

3,707 people reported to have side effects when taking Glycopyrrolate.
Among them, 50 people (1.35%) have Anaphylaxis.

What is Glycopyrrolate?

Glycopyrrolate has active ingredients of glycopyrrolate. It is often used in hyperhidrosis. eHealthMe is studying from 3,777 Glycopyrrolate users for its effectiveness, alternative drugs and more.

What is Anaphylaxis?

Anaphylaxis (serious allergic reaction that is rapid in onset and may cause death) is found to be associated with 3,178 drugs and 2,641 conditions by eHealthMe.

Number of Glycopyrrolate and Anaphylaxis reports submitted per year:

Time on Glycopyrrolate when people have Anaphylaxis *:

Gender of people who have Anaphylaxis when taking Glycopyrrolate *:

female: 74.42 %
male: 25.58 %

Age of people who have Anaphylaxis when taking Glycopyrrolate *:

Common drugs people take besides Glycopyrrolate *:

Ranitidine: 14 people, 28.00%
Chlorpheniramine Maleate: 13 people, 26.00%
Dexamethasone: 13 people, 26.00%
Oxycodone: 12 people, 24.00%
Lansoprazole: 12 people, 24.00%
Lactulose: 12 people, 24.00%
Hydrocortisone: 12 people, 24.00%
Docetaxel: 12 people, 24.00%
Levetiracetam: 12 people, 24.00%
Ventolin: 12 people, 24.00%

Common side effects people have besides Anaphylaxis *:

Diarrhea: 18 people, 36.00%
Itching: 17 people, 34.00%
Memory Loss: 16 people, 32.00%
Chest Pain: 15 people, 30.00%
Fatigue (feeling of tiredness): 14 people, 28.00%
Constipation: 13 people, 26.00%
Nail Dystrophy (bed formation of nail): 12 people, 24.00%
Panic Disorder: 12 people, 24.00%
Axillary Pain: 12 people, 24.00%
Asthma: 12 people, 24.00%

Common conditions people have *:

Insomnia (sleeplessness): 12 people, 24.00%
Asthma: 11 people, 22.00%
Infection: 10 people, 20.00%
Breast Cancer Metastatic: 9 people, 18.00%
Lacrimation Increased: 9 people, 18.00%
Itching: 9 people, 18.00%
Panic Disorder: 8 people, 16.00%
Constipation: 7 people, 14.00%
Dry Skin: 7 people, 14.00%
Hypersensitivity: 7 people, 14.00%

* Approximation only. Some reports may have incomplete information.

Do you take Glycopyrrolate and have Anaphylaxis?

Check whether Anaphylaxis is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related publications that referenced our studies

An?eli? N, Erdeljan S, Popovi? R, Bo?i? T, "Anaphylaxis on graft reperfusion during orthotopic liver transplantation: A case study", Srpski arhiv za celokupno lekarstvo, 2016 Jan .
D'souza S, Gowler V, "Glycopyrrolate‐induced respiratory arrest: an unusual side effect", Acta Anaesthesiologica Scandinavica, 2015 Mar .
Thangakunam B, Christopher DJ, Mathews V, Srivastava A, "Mesenchymal stromal stem cell therapy in advanced interstitial lung disease-Anaphylaxis and short-term follow-up", Lung India: official organ of Indian Chest Society, 2015 Jan .
Guensley Delva, M. D., & Muse, I, "Rare case of laryngeal edema and anaphylaxis to Ofirmev (IV Acetaminophen): Case Report", , 2012 Jan .
Azkur D, Yoldas T, Toyran M, Kocabas CN, "A pediatric case of anaphylaxis due to octreotide", Asian Pacific journal of allergy and immunology, 2011 Dec .

Related studies

How severe was Anaphylaxis and when was it recovered:

Anaphylaxis in Glycopyrrolate

Expand to all the drugs that have ingredients of glycopyrrolate:

Anaphylaxis and drugs with ingredients of glycopyrrolate (100 reports)

Alternative drugs to, pros and cons of Glycopyrrolate:

Glycopyrrolate (3,777 reports)

Common Glycopyrrolate side effects:

Browse all side effects of Glycopyrrolate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Anaphylaxis treatments and more:

Anaphylaxis (78,714 reports)

COVID vaccines that are related to Anaphylaxis:

Common drugs associated with Anaphylaxis:

All the drugs that are associated with Anaphylaxis:

Anaphylaxis (3,178 drugs)

Common conditions associated with Anaphylaxis:

All the conditions that are associated with Anaphylaxis:

Anaphylaxis (2,641 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on glycopyrrolate (the active ingredients of Glycopyrrolate) and Glycopyrrolate (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.